Revolutionizing Healthcare: The Impact of AI Disruption in Clinical Trials

H1 CEO Ariel Katz leads a panel focused on the integration of artificial intelligence in clinical trials and the profound transformation and impact on the efficiency, accuracy, and innovation in trial design as a result. Panelists examine how the application of AI in patient recruitment, data analysis, and personalized medicine can provide unprecedented opportunities that will reshape the future of healthcare.

Industry leaders on the panel include:

- Stephanie Butler, Senior Conference Production Director, Fierce Life Sciences
- Okan Ekinci, Head of Innovation, Roche Information Solution (RIS)
- Patrick Loerch, Senior Vice President of Clinical Data Science, Gilead Sciences
- David Feinberg, MD, Chairman, Oracle Health
- Christoph Koenen, MD, Global Development and Clinical Operations, Pharmaceuticals Research & Development, Bayer